Literature DB >> 20673090

Validation of a urine test and characterization of the putative genetic mutation for hyperuricosuria in Bulldogs and Black Russian Terriers.

Nili Karmi1, Noa Safra, Amy Young, Danika L Bannasch.   

Abstract

OBJECTIVE: To determine whether hyperuricosuria was a predisposing factor for urate urolithiasis in Bulldogs and Black Russian Terriers (BRTs) and to estimate the allele frequency of the Cys181Phe genetic mutation in urate transporter SLC2A9 in these breeds. ANIMALS: 192 Bulldogs, 101 BRTs, 10 Dalmatians, and 9 dogs of other breeds. PROCEDURES: Uric acid (UA) and creatinine (Cr) concentrations were quantified in urine samples collected from all dogs via midstream catch during natural voiding. Buccal swab or blood samples were also obtained, and DNA was extracted and used to genotype SLC2A9 sequence variants by use of pyrosequencing assays. A urine test for hyperuricosuria was validated in adult dogs by comparing urinary UA:Cr ratios between known hyperuricosuric and nonhyperuricosuric dogs.
RESULTS: Significantly higher UA:Cr ratios were found in some Bulldogs and BRTs, compared with ratios in other dogs from these breeds. These dogs were also homozygous for the SLC2A9 Cys181Phe mutation. The allele frequency of the Cys181Phe mutation was 0.16 in Bulldogs and 0.51 in BRTs. On the basis of these allele frequencies, 3% of the Bulldog population and 27% of the BRT population were estimated to be hyperuricosuric. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggested the genetic mutation associated with hyperuricosuria, first identified in Dalmatians, also appears to cause hyperuricosuria in Bulldogs and BRTs, indicating that similar management strategies for urate urolithiasis can be used in these breeds. The allele frequency of the mutation was high in both breeds, and DNA testing can be used to select against the mutation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20673090      PMCID: PMC5551899          DOI: 10.2460/ajvr.71.8.909

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  27 in total

Review 1.  Pyrosequencing: history, biochemistry and future.

Authors:  Afshin Ahmadian; Maria Ehn; Sophia Hober
Journal:  Clin Chim Acta       Date:  2005-09-13       Impact factor: 3.786

2.  Linkage analysis with an interbreed backcross maps Dalmatian hyperuricosuria to CFA03.

Authors:  Noa Safra; Robert H Schaible; Danika L Bannasch
Journal:  Mamm Genome       Date:  2006-04-04       Impact factor: 2.957

3.  Ammonium urate urolith resulting in hydronephrosis and hydroureter in a dog with a congenital portosystemic shunt.

Authors:  J M da Silva Curiel; E R Pope; D P O'brien; D A Schmidt
Journal:  Can Vet J       Date:  1990-02       Impact factor: 1.008

4.  Genetic predisposition to purine uroliths in Dalmatian dogs.

Authors:  R H Schaible
Journal:  Vet Clin North Am Small Anim Pract       Date:  1986-01       Impact factor: 2.093

5.  Urine uric acid to creatinine rtio--a screening test for inherited disorders of purine metabolism. Phosphoribosyltransferase (PRT) deficiency in X-linked cerebral palsy and in a variant of gout.

Authors:  J M Kaufman; M L Greene; J E Seegmiller
Journal:  J Pediatr       Date:  1968-10       Impact factor: 4.406

Review 6.  Diagnosis, prevention, and treatment of urate urolithiasis in Dalmatians.

Authors:  J L Sorenson; G V Ling
Journal:  J Am Vet Med Assoc       Date:  1993-09-15       Impact factor: 1.936

Review 7.  Metabolic and genetic aspects of urate urolithiasis in Dalmatians.

Authors:  J L Sorenson; G V Ling
Journal:  J Am Vet Med Assoc       Date:  1993-09-15       Impact factor: 1.936

8.  Loss of urate oxidase activity in hominoids and its evolutionary implications.

Authors:  Masako Oda; Yoko Satta; Osamu Takenaka; Naoyuki Takahata
Journal:  Mol Biol Evol       Date:  2002-05       Impact factor: 16.240

9.  Breed distribution and history of canine mdr1-1Delta, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage.

Authors:  Mark W Neff; Kathryn R Robertson; Aaron K Wong; Noa Safra; Karl W Broman; Montgomery Slatkin; Katrina L Mealey; Niels C Pedersen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

10.  Prevalence of cystine and urate uroliths in bulldogs and urate uroliths in dalmatians.

Authors:  J W Bartges; C A Osborne; J P Lulich; L K Unger; L A Koehler; K A Bird; C W Clinton; M P Davenport
Journal:  J Am Vet Med Assoc       Date:  1994-06-15       Impact factor: 1.936

View more
  6 in total

1.  Primary portal vein hypoplasia and SLC2A9 mutation associated with urate urolithiasis in a Spanish water dog.

Authors:  Laura Cosgrove; Gawain Hammond; Gerard Mclauchlan
Journal:  Can Vet J       Date:  2015-11       Impact factor: 1.008

2.  Estimated frequency of the canine hyperuricosuria mutation in different dog breeds.

Authors:  N Karmi; E A Brown; S S Hughes; B McLaughlin; C S Mellersh; V Biourge; D L Bannasch
Journal:  J Vet Intern Med       Date:  2010 Nov-Dec       Impact factor: 3.333

3.  Localization of canine brachycephaly using an across breed mapping approach.

Authors:  Danika Bannasch; Amy Young; Jeffrey Myers; Katarina Truvé; Peter Dickinson; Jeffrey Gregg; Ryan Davis; Eric Bongcam-Rudloff; Matthew T Webster; Kerstin Lindblad-Toh; Niels Pedersen
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

4.  A genetic assessment of the English bulldog.

Authors:  Niels C Pedersen; Ashley S Pooch; Hongwei Liu
Journal:  Canine Genet Epidemiol       Date:  2016-07-29

5.  Genetic Panel Screening of Nearly 100 Mutations Reveals New Insights into the Breed Distribution of Risk Variants for Canine Hereditary Disorders.

Authors:  Jonas Donner; Maria Kaukonen; Heidi Anderson; Fredrik Möller; Kaisa Kyöstilä; Satu Sankari; Marjo Hytönen; Urs Giger; Hannes Lohi
Journal:  PLoS One       Date:  2016-08-15       Impact factor: 3.240

6.  Calcium oxalate urolithiasis in juvenile dogs.

Authors:  Alexander Saver; Jody P Lulich; Samantha Van Buren; Eva Furrow
Journal:  Vet Rec       Date:  2021-02-10       Impact factor: 2.560

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.